Skip to Content

Medications for Ovarian Cancer

Other names: Cancer, Ovarian; Cancer, Ovaries

What is Ovarian Cancer:  Ovarian cancer is a malignant neoplasm (abnormal growth) located on the ovaries.

Medications to treat Ovarian Cancer

The following list of medications are in some way related to, or used in the treatment of this condition.

Drug name Rx / OTC Pregnancy CSA Alcohol Reviews Rating Popularity
carboplatin D N 2 reviews
9.0

Generic name: carboplatin systemic

Brand name:  Paraplatin

Drug class: alkylating agents

For consumers: dosage, interactions, side effects

For professionals: A-Z Drug Facts, AHFS DI Monograph, Prescribing Information

 
Avastin C N 4 reviews
4.0

Generic name: bevacizumab systemic

Drug class: VEGF/VEGFR inhibitors

For consumers: dosage, interactions, side effects

For professionals: AHFS DI Monograph, Prescribing Information

 
Taxol D N 1 review
9.0

Generic name: paclitaxel systemic

Drug class: mitotic inhibitors

For consumers: dosage, interactions, side effects

For professionals: Prescribing Information

 
Doxil D N Add review Rate

Generic name: doxorubicin liposomal systemic

Drug class: antibiotics/antineoplastics

For consumers: dosage, interactions, side effects

 
paclitaxel D N 2 reviews
8.0

Generic name: paclitaxel systemic

Brand name:  Taxol

Drug class: mitotic inhibitors

For consumers: dosage, interactions, side effects

For professionals: A-Z Drug Facts, AHFS DI Monograph, Prescribing Information

 
Adriamycin D N Add review Rate

Generic name: doxorubicin systemic

Drug class: antibiotics/antineoplastics

For consumers: dosage, interactions, side effects

For professionals: Prescribing Information

 
Gemzar D N Add review Rate

Generic name: gemcitabine systemic

Drug class: antimetabolites

For consumers: dosage, interactions, side effects

For professionals: AHFS DI Monograph, Prescribing Information

 
Alkeran D N Add review Rate

Generic name: melphalan systemic

Drug class: alkylating agents

For consumers: dosage, interactions, side effects

For professionals: AHFS DI Monograph, Prescribing Information

 
Paraplatin D N 2 reviews
9.0

Generic name: carboplatin systemic

Drug class: alkylating agents

For consumers: dosage, interactions, side effects

For professionals: AHFS DI Monograph, Prescribing Information

 
doxorubicin liposomal D N Add review Rate

Generic name: doxorubicin liposomal systemic

Brand name:  Doxil

Drug class: antibiotics/antineoplastics

For consumers: dosage, interactions, side effects

For professionals: A-Z Drug Facts

 
Hexalen D N 1 review
7.0

Generic name: altretamine systemic

Drug class: miscellaneous antineoplastics

For consumers: dosage, interactions, side effects

For professionals: AHFS DI Monograph, Prescribing Information

 
doxorubicin D N 1 review Rate

Generic name: doxorubicin systemic

Brand name:  Adriamycin

Drug class: antibiotics/antineoplastics

For consumers: dosage, interactions, side effects

For professionals: A-Z Drug Facts, AHFS DI Monograph, Prescribing Information

 
gemcitabine D N Add review Rate

Generic name: gemcitabine systemic

Brand name:  Gemzar

Drug class: antimetabolites

For consumers: dosage, interactions, side effects

For professionals: A-Z Drug Facts, AHFS DI Monograph, Prescribing Information

 
Cosmegen D N Add review Rate

Generic name: dactinomycin systemic

Drug class: antibiotics/antineoplastics

For consumers: dosage, interactions, side effects

For professionals: AHFS DI Monograph, Prescribing Information

 
cisplatin D N Add review Rate

Generic name: cisplatin systemic

Brand names:  Platinol, Platinol-AQ

Drug class: alkylating agents

For consumers: dosage, interactions, side effects

For professionals: A-Z Drug Facts, AHFS DI Monograph, Prescribing Information

 
topotecan D N Add review Rate

Generic name: topotecan systemic

Brand name:  Hycamtin

Drug class: miscellaneous antineoplastics

For consumers: dosage, interactions, side effects

For professionals: A-Z Drug Facts, AHFS DI Monograph, Prescribing Information

 
melphalan D N Add review Rate

Generic name: melphalan systemic

Brand name:  Alkeran

Drug class: alkylating agents

For consumers: dosage, interactions, side effects

For professionals: A-Z Drug Facts, AHFS DI Monograph, Prescribing Information

 
Platinol D N Add review Rate

Generic name: cisplatin systemic

Drug class: alkylating agents

For consumers: dosage, interactions, side effects

For professionals: Prescribing Information

 
Ethyol C N Add review Rate

Generic name: amifostine systemic

Drug class: antineoplastic detoxifying agents

For consumers: dosage, interactions, side effects

For professionals: AHFS DI Monograph, Prescribing Information

 
Toposar D N Add review Rate

Generic name: etoposide systemic

Drug class: mitotic inhibitors

For consumers: dosage, interactions, side effects

For professionals: Prescribing Information

 
VePesid D N Add review Rate

Generic name: etoposide systemic

Drug class: mitotic inhibitors

For consumers: dosage, interactions, side effects

For professionals: Prescribing Information

 
Hycamtin D N Add review Rate

Generic name: topotecan systemic

Drug class: miscellaneous antineoplastics

For consumers: dosage, interactions, side effects

For professionals: AHFS DI Monograph, Prescribing Information

 
methotrexate Off Label X N X Add review Rate

Generic name: methotrexate systemic

Drug class: antimetabolites, antirheumatics, antipsoriatics, other immunosuppressants

For consumers: dosage, interactions, side effects

For professionals: A-Z Drug Facts, AHFS DI Monograph, Prescribing Information

Off Label: Yes

 
olaparib D N Add review Rate

Generic name: olaparib systemic

Brand name:  Lynparza

Drug class: PARP inhibitors

For consumers: dosage, interactions, side effects

For professionals: A-Z Drug Facts, AHFS DI Monograph

 
Etopophos D N Add review Rate

Generic name: etoposide systemic

Drug class: mitotic inhibitors

For consumers: dosage, interactions, side effects

For professionals: Prescribing Information

 
Page 1 2 Next

Learn more about Ovarian Cancer

Legend

Off Label This medication may not be approved by the FDA for the treatment of this condition.
Prescription Only / Over the Counter
Rx Prescription Only
OTC Over the Counter
Rx/OTC Prescription or Over the Counter
Pregnancy
A Adequate and well-controlled studies have failed to demonstrate a risk to the fetus in the first trimester of pregnancy (and there is no evidence of risk in later trimesters).
B Animal reproduction studies have failed to demonstrate a risk to the fetus and there are no adequate and well-controlled studies in pregnant women.
C Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use in pregnant women despite potential risks.
D There is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience or studies in humans, but potential benefits may warrant use in pregnant women despite potential risks.
X Studies in animals or humans have demonstrated fetal abnormalities and/or there is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience, and the risks involved in use in pregnant women clearly outweigh potential benefits.
N FDA has not classified the drug.
Controlled Substances Act Schedule
N Is not subject to the Controlled Substances Act.
1 Has a high potential for abuse. Has no currently accepted medical use in treatment in the United States. There is a lack of accepted safety for use under medical supervision.
2 Has a high potential for abuse. Has a currently accepted medical use in treatment in the United States or a currently accepted medical use with severe restrictions. Abuse may lead to severe psychological or physical dependence.
3 Has a potential for abuse less than those in schedules 1 and 2. Has a currently accepted medical use in treatment in the United States. Abuse may lead to moderate or low physical dependence or high psychological dependence.
4 Has a low potential for abuse relative to those in schedule 3. It has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to those in schedule 3.
5 Has a low potential for abuse relative to those in schedule 4. Has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to those in schedule 4.
Alcohol
X Interacts with Alcohol.

Browse Drugs by Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Hide